You are here

Industry News

Advamed Smart Brief

February 28, 2017
Johnson & Johnson has announced the completion of its acquisition of Abbott Laboratories subsidiary Abbott Medical Optics, va -More
February 28, 2017
An equity offering involving 23 investors has brought in $4.6 million for Durham, N.C.-based TrackX Technology, a maker of ha -More
February 28, 2017
A partnership has been reached by Royal Philips and German digital health startup Onelife Health to create solutions for mate -More
February 28, 2017
Days after India's National Pharmaceutical Pricing Authority ordered a price cap on coronary stents, Chinese medtech company  -More
February 28, 2017
A GlobalData analysis predicts the Asia-Pacific market for bone growth stimulators will reach $29.3 million by 2023 with a co -More
February 28, 2017
The medical device industry should not treat cybersecurity as though it were a check box -- and it may want to brush up on th -More
February 28, 2017
Five-year economic analysis data from a study in the Journal of the American College of Cardiology: Heart Failure was release -More
February 28, 2017
The FDA has given Royal Philips 510(k) clearance for its ElastQ Imaging capability, which allows for simultaneous tissue imag -More
February 28, 2017
The G5 Mobile CGM System has been released by Dexcom for use in making treatment decisions for patients ages 2 and older with -More
February 28, 2017
The FDA has granted San Francisco-based Velano Vascular 510(k) clearance for its Pivo needle-free vascular access device, whi -More

Industry News

Fox Business
AdvaMed CEO Scott Whitaker on the impact of Obamacare and its medical device tax. ​​​​
Wisconsin State Journal
The United States has long been a leader in medical technology innovation and discovery, and Wisconsin has been a leading state in medical breakthroughs and medical device manufacturing. Unfortunately, we have tax policies, including the medical device tax, that have stifled innovation and job creation, putting our research and technological leadership at risk.
The Journal Gazette
From artificial joints to replacement heart valves, hospital beds to radiation therapies, the economic and human impact of medical technology innovation cannot be overstated. Medical technology companies that innovate quickly and at high levels of quality create and sustain well-paying jobs and, most importantly, save and improve the lives of patients. And that is why permanent repeal of the medical device tax must be a priority for the 115th Congress in 2017. The 2.3 percent excise tax on...
Houston Chronicle
Tax reform and health care reform are likely to be on the agendas of both the incoming Trump administration and the 115th Congress. Promoting medical innovation should be a national priority, as well. And that is why permanent repeal of the medical device tax must be a priority.
Salt Lake Tribune
In an undeniable victory for patients and medical innovation, last month Congress passed historic legislation known as the 21st Century Cures Act. When fully implemented, this legislation will help accelerate the discovery, development and delivery of medical advancements to ensure more timely access to new treatments and cures for patients in need. Passage of the legislation would not have been possible without support from both sides of the political aisle, including U.S. Sen. Orrin Hatch....